Saturday 17 October 2026
Export OSRH’s income statement to Excel — free account
OSR Health, Inc.
OSRH Healthcare Biotechnology
OSR Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 million, down 17.7% from fiscal 2024. In the quarter to June 2026, revenue fell 72.2%, EPS fell 200.0%, free cash flow fell 398.8% and total debt rose 28.2%, each against the same quarter a year earlier.
0.22
0.02
+10.00%
Follow OSRH
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(22.63%) | (20.03%) | (14.32%) | (14.98%) | |
| (14.68%) | (15.62%) | (10.73%) | (11.24%) | ||
ROIC |
(6.22%) | (8.84%) | (9.12%) | (8.19%) | |
Return on Tangible Assets |
123.85% | 190.83% | 125.48% | 155.41% | |
Average Days of Receivables |
56.65 | 49.25 | 44.39 | 49.26 | |
Free Cash Flow per Share |
(0.16) | (0.24) | (0.17) | (0.22) | |
Free Cash Flow |
(3.44) | (4.76) | (5.27) | (7.20) | |
Capital Expenditures |
0.00 | (0.43) | — | — | |
| Other line items | |||||
Cash ROIC |
(2.44%) | (3.58%) | (3.93%) | (5.46%) | |
Accounts Receivable Turnover |
0.00 | 4.38 | 4.70 | 3.63 | |
Accounts Payable Turnover |
0.63 | 0.52 | 0.26 | 0.15 | |
Inventory Turnover |
0.00 | 4.14 | 3.41 | 2.95 | |
Average Days of Payables |
993.14 | 1,235.67 | 1,475.39 | 2,496.34 | |
Days of Inventory on Hand |
23.99 | 30.99 | 82.59 | 185.32 | |
Tax Rate |
(0.12) | (0.08) | (0.13) | (0.15) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
412.43% | 651.42% | 748.30% | 969.01% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(109.56) | (36.22) | (36.63) | (34.00) | |
Operating CF/Net income |
0.24 | 0.16 | 0.28 | 0.36 | |
Depreciation/Fixed assets |
83.23 | 55.03 | 61.62 | 66.55 | |
Capex/Depreciation |
0.00 | (0.05) | 0.00 | 0.00 | |
Revenue per Share |
0.16 | 0.15 | 0.08 | 0.06 | |
Operating CF per Share |
(0.16) | (0.22) | (0.17) | (0.22) | |
Capex per Share |
0.00 | (0.02) | 0.00 | 0.00 | |
Capex to Sales |
0.00 | 0.15 | 0.00 | 0.00 |
Columns are period end dates